The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy.
Eiben
Gretchen L
GL
Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood Illinois 60153, USA.
Velders
Markwin P
MP
Kast
W Martin
WM
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D019496:Cancer Vaccines / Q000145:classification / Q000627:therapeutic use; D004279:DNA, Viral / Q000235:genetics; D005260:Female; D005814:Genes, Viral; D005822:Genetic Vectors / Q000627:therapeutic use; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007157:Immunologic Surveillance; D007167:Immunotherapy; D051379:Mice; D008822:Mice, Transgenic; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000502:physiology; D027383:Papillomaviridae / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D030361:Papillomavirus Infections / Q000453:epidemiology / Q000276:immunology* / Q000821:virology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019139:Tumor Escape; D014412:Tumor Virus Infections / Q000453:epidemiology / Q000276:immunology* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000276:immunology* / Q000628:therapy / Q000821:virology
D019496:Cancer Vaccines; D004279:DNA, Viral; D006680:HLA Antigens; D009856:Oncogene Proteins, Viral